Company Overview
About Tamarind Bio
Tamarind Bio is a San Francisco-based computational biology platform — backed by Y Combinator (W24) with $14.1 million raised including a $500,000 seed in 2024 and a $13.6 million Series A in May 2025 — providing pharmaceutical companies, biotechs, and academic researchers with no-code API access to advanced computational biology tools (AlphaFold protein structure prediction, antibody engineering models, protein-protein interaction prediction, molecular dynamics simulation) that historically required high-performance computing infrastructure, specialized bioinformatics expertise, and weeks of computational time to run. Founded in 2023 with a 7-person team, Tamarind serves thousands of researchers across large pharma companies, biotech startups, and academic institutions that need computational biology capabilities without building or maintaining HPC infrastructure.
Business Model & Competitive Advantage
Tamarind's no-code bioinformatics API abstracts the computational biology complexity that prevents wet lab biologists from accessing the transformative machine learning tools their field has developed: a medicinal chemist at a biotech who needs to predict how a protein mutation affects antibody binding affinity can submit a sequence and get structure-informed binding predictions via API within minutes — without knowing how to run AlphaFold on a GPU cluster, configure molecular dynamics software, or interpret raw simulation output files. The platform provides pre-validated workflows ('antibody optimization,' 'epitope mapping,' 'off-target binding prediction') that translate researcher questions into the appropriate computational methods and return results in interpretable formats (binding probability scores, structural visualization, ranked variant libraries). This democratization of computational biology accelerates drug discovery timelines by enabling faster hypothesis testing without specialized bioinformatics team involvement.
Competitive Landscape 2025–2026
In 2025, Tamarind Bio competes in the computational biology SaaS and AI drug discovery tools market with Schrödinger (NASDAQ: SDGR, physics-based molecular simulation software, $500M+ revenue), Dotmatics (scientific software, $900M Insight acquisition), and Benchling (life sciences R&D software, $200M raised at $6.1B valuation) for pharmaceutical computational biology platform adoption. The computational biology market has been transformed by AlphaFold (DeepMind's protein structure prediction breakthrough) and the subsequent wave of structure-informed drug design — companies that can rapidly predict protein structure and model drug-protein interactions computationally reduce the experimental cycles that previously required months of crystallography or cryo-EM. Y Combinator W24 backing positions Tamarind at the intersection of AI and drug discovery that has attracted significant investment. The 2025 strategy focuses on growing pharmaceutical company API subscriptions for large-scale virtual screening campaigns, building the antibody engineering workflow for biologics development teams, and expanding academic institution access through consortium licensing for non-commercial research.
Recent Activity
View all →Key Differentiators
Emerging Innovator
Tamarind Bio is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Browser Use
Browser Use is an open-source project that provides a Python library allowing AI agents and large language models to control web browsers as a tool. The library sits between LLM APIs and browser autom
Oracle Health
Oracle Health is the healthcare technology business unit of Oracle Corporation (NYSE: ORCL) — providing electronic health records (EHR), clinical workflow management, health information exchange, reve
athenahealth
athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on
Veeva Systems
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executiv
Idexx Laboratories
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headqu
Revvity
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provid
Compare Tamarind Bio with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Tamarind Bio? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Tamarind Bio Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Tamarind Bio vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →